PortalPublikationenBiomarCaRE

BiomarCaRE

Standard

BiomarCaRE : rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. / Zeller, Tanja; Hughes, Maria; Tuovinen, Tarja; Schillert, Arne; Conrads-Frank, Annette; Ruijter, Hester den; Schnabel, Renate B; Kee, Frank; Salomaa, Veikko; Siebert, Uwe; Thorand, Barbara; Ziegler, Andreas; Breek, Heico; Pasterkamp, Gerard; Kuulasmaa, Kari; Koenig, Wolfgang; Blankenberg, Stefan.

in: EUR J EPIDEMIOL, Jahrgang 29, Nr. 10, 10.2014, S. 777-790.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Zeller, T, Hughes, M, Tuovinen, T, Schillert, A, Conrads-Frank, A, Ruijter, HD, Schnabel, RB, Kee, F, Salomaa, V, Siebert, U, Thorand, B, Ziegler, A, Breek, H, Pasterkamp, G, Kuulasmaa, K, Koenig, W & Blankenberg, S 2014, 'BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries', EUR J EPIDEMIOL, Jg. 29, Nr. 10, S. 777-790. https://doi.org/10.1007/s10654-014-9952-x

APA

Zeller, T., Hughes, M., Tuovinen, T., Schillert, A., Conrads-Frank, A., Ruijter, H. D., Schnabel, R. B., Kee, F., Salomaa, V., Siebert, U., Thorand, B., Ziegler, A., Breek, H., Pasterkamp, G., Kuulasmaa, K., Koenig, W., & Blankenberg, S. (2014). BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. EUR J EPIDEMIOL, 29(10), 777-790. https://doi.org/10.1007/s10654-014-9952-x

Vancouver

Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, Ruijter HD et al. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. EUR J EPIDEMIOL. 2014 Okt;29(10):777-790. https://doi.org/10.1007/s10654-014-9952-x

Bibtex

@article{7212585a10fe44b4ad3c0789528e82e9,
title = "BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries",
abstract = "Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond European risk scores, their comparative impact among different European regions and their role towards personalised medicine remains uncertain. Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE) is an European collaborative research project with the primary objective to assess the value of established and emerging biomarkers for cardiovascular risk prediction. BiomarCaRE integrates clinical and epidemiological biomarker research and commercial enterprises throughout Europe to combine innovation in biomarker discovery for cardiovascular disease prediction with consecutive validation of biomarker effectiveness in large, well-defined primary and secondary prevention cohorts including over 300,000 participants from 13 European countries. Results from this study will contribute to improved cardiovascular risk prediction across different European populations. The present publication describes the rationale and design of the BiomarCaRE project. ",
keywords = "Adult, Aged, Biomarkers/blood, Cardiovascular Diseases/blood, Cooperative Behavior, Databases, Factual, European Continental Ancestry Group, European Union, Female, Follow-Up Studies, Humans, International Cooperation, Male, MicroRNAs/blood, Middle Aged, Pilot Projects, Population Surveillance/methods, Prospective Studies, Risk Factors",
author = "Tanja Zeller and Maria Hughes and Tarja Tuovinen and Arne Schillert and Annette Conrads-Frank and Ruijter, {Hester den} and Schnabel, {Renate B} and Frank Kee and Veikko Salomaa and Uwe Siebert and Barbara Thorand and Andreas Ziegler and Heico Breek and Gerard Pasterkamp and Kari Kuulasmaa and Wolfgang Koenig and Stefan Blankenberg",
year = "2014",
month = oct,
doi = "10.1007/s10654-014-9952-x",
language = "English",
volume = "29",
pages = "777--790",
journal = "EUR J EPIDEMIOL",
issn = "0393-2990",
publisher = "Springer",
number = "10",

}

RIS

TY - JOUR

T1 - BiomarCaRE

T2 - rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries

AU - Zeller, Tanja

AU - Hughes, Maria

AU - Tuovinen, Tarja

AU - Schillert, Arne

AU - Conrads-Frank, Annette

AU - Ruijter, Hester den

AU - Schnabel, Renate B

AU - Kee, Frank

AU - Salomaa, Veikko

AU - Siebert, Uwe

AU - Thorand, Barbara

AU - Ziegler, Andreas

AU - Breek, Heico

AU - Pasterkamp, Gerard

AU - Kuulasmaa, Kari

AU - Koenig, Wolfgang

AU - Blankenberg, Stefan

PY - 2014/10

Y1 - 2014/10

N2 - Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond European risk scores, their comparative impact among different European regions and their role towards personalised medicine remains uncertain. Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE) is an European collaborative research project with the primary objective to assess the value of established and emerging biomarkers for cardiovascular risk prediction. BiomarCaRE integrates clinical and epidemiological biomarker research and commercial enterprises throughout Europe to combine innovation in biomarker discovery for cardiovascular disease prediction with consecutive validation of biomarker effectiveness in large, well-defined primary and secondary prevention cohorts including over 300,000 participants from 13 European countries. Results from this study will contribute to improved cardiovascular risk prediction across different European populations. The present publication describes the rationale and design of the BiomarCaRE project.

AB - Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond European risk scores, their comparative impact among different European regions and their role towards personalised medicine remains uncertain. Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE) is an European collaborative research project with the primary objective to assess the value of established and emerging biomarkers for cardiovascular risk prediction. BiomarCaRE integrates clinical and epidemiological biomarker research and commercial enterprises throughout Europe to combine innovation in biomarker discovery for cardiovascular disease prediction with consecutive validation of biomarker effectiveness in large, well-defined primary and secondary prevention cohorts including over 300,000 participants from 13 European countries. Results from this study will contribute to improved cardiovascular risk prediction across different European populations. The present publication describes the rationale and design of the BiomarCaRE project.

KW - Adult

KW - Aged

KW - Biomarkers/blood

KW - Cardiovascular Diseases/blood

KW - Cooperative Behavior

KW - Databases, Factual

KW - European Continental Ancestry Group

KW - European Union

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - International Cooperation

KW - Male

KW - MicroRNAs/blood

KW - Middle Aged

KW - Pilot Projects

KW - Population Surveillance/methods

KW - Prospective Studies

KW - Risk Factors

U2 - 10.1007/s10654-014-9952-x

DO - 10.1007/s10654-014-9952-x

M3 - SCORING: Journal article

C2 - 25238720

VL - 29

SP - 777

EP - 790

JO - EUR J EPIDEMIOL

JF - EUR J EPIDEMIOL

SN - 0393-2990

IS - 10

ER -